FLT
FLT (Fms-like tyrosine kinase) inhibitors are compounds that target FLT receptors, which are involved in the regulation of angiogenesis through the VEGF (vascular endothelial growth factor) pathway. FLT receptors play a crucial role in the development of new blood vessels in tumors. Inhibiting FLT receptors can effectively reduce angiogenesis and tumor growth, making these inhibitors important in cancer therapy. At CymitQuimica, we offer a selection of high-quality FLT inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
Crenolanib
CAS:670220-88-9
Crenolanib (ARO 002) is an orally bioavailable type III tyrosine kinases inhibitor of PDGFRα/β and …
Formula:
C26H29N5O2
Purity:
97.45% - 99.28%
Color and Shape:
Solid
Molecular weight:
443.54
Ref: TM-T2677
| 2mg | 58.00 € | ||
| 5mg | 89.00 € | ||
| 10mg | 130.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 269.00 € | ||
| 100mg | 444.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
TCS 359
CAS:301305-73-7
TCS 359 (FLT3 Inhibitor) is a potent FLT3 inhibitor with IC50 of 42 nM.
Formula:
C18H20N2O4S
Purity:
99.31%
Color and Shape:
Solid
Molecular weight:
360.43
Ref: TM-T6138
| 5mg | 37.00 € | ||
| 10mg | 52.00 € | ||
| 25mg | 93.00 € | ||
| 50mg | 156.00 € | ||
| 100mg | 195.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
UNC2025
CAS:1429881-91-3
UNC2025 (mrx-6313)(IC50 of 0.74 nM and 0.8 nM) is a potent and orally bioavailable dual …
Formula:
C28H40N6O
Purity:
99.53% - 99.74%
Color and Shape:
Solid
Molecular weight:
476.66
Ref: TM-T7007
| 2mg | 39.00 € | ||
| 5mg | 57.00 € | ||
| 10mg | 93.00 € | ||
| 25mg | 124.00 € | ||
| 50mg | 197.00 € | ||
| 100mg | 350.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
AMG 925
CAS:1401033-86-0
AMG 925 is a potent and orally bioavailable dual FLT3/CDK4 inhibitor with IC50 of 1 …
Formula:
C26H29N7O2
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
471.55
Ref: TM-T6756
| 1mg | 35.00 € | ||
| 2mg | 50.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 274.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
CCT241736
CAS:1402709-93-6
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant …
Formula:
C22H23Cl2N7
Purity:
96.2% - 99.88%
Color and Shape:
Solid
Molecular weight:
456.37
Ref: TM-T4428
| 5mg | 60.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 329.00 € | ||
| 100mg | 494.00 € | ||
| 1mL*10mM (DMSO) | 66.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
NVP-AEW541
CAS:475489-16-8
NVP-AEW541 (AEW541), a potent inhibitor of IGF-1R(IC50=150 nM) and InsR(IC50=140 nM), exhibits excellent efficiency and …
Formula:
C27H29N5O
Purity:
96.03% - 99.55%
Color and Shape:
Solid
Molecular weight:
439.55
Ref: TM-T6080
| 1mg | 48.00 € | ||
| 2mg | 65.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 271.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
BPR1J-097
CAS:1327167-19-0
BPR1J-097) is a novel FLT-3 inhibitor(IC50: 11±7 nM) with promising in vivo anti-tumor activities. It …
Formula:
C27H28N6O3S
Purity:
99.3%
Color and Shape:
Solid
Molecular weight:
516.61
Ref: TM-T2272
| 2mg | 55.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 106.00 € | ||
| 25mg | 225.00 € | ||
| 50mg | 384.00 € | ||
| 100mg | 555.00 € | ||
| 1mL*10mM (DMSO) | 117.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
5'-Fluoroindirubinoxime
CAS:861214-33-7
5'-Fluoroindirubinoxime (5'-FIO) is a potent FLT3 inhibitor( IC50 : 15 nM).
Formula:
C16H10FN3O2
Purity:
100%
Color and Shape:
Solid
Molecular weight:
295.27
Ref: TM-T8317
| 1mg | 49.00 € | ||
| 5mg | 97.00 € | ||
| 10mg | 154.00 € | ||
| 25mg | 274.00 € | ||
| 50mg | 406.00 € | ||
| 100mg | 592.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
FLT3-IN-2
CAS:923562-23-6
FLT3-IN-2 is an FLT3 inhibitor (IC50<1 μM).
Formula:
C21H16ClF3N4
Purity:
97.57% - 98.53%
Color and Shape:
Solid
Molecular weight:
416.83
Ref: TM-T1938
| 1mg | 43.00 € | ||
| 2mg | 56.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 210.00 € | ||
| 50mg | 350.00 € | ||
| 100mg | 505.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Crotonoside
CAS:1818-71-9
Crotonoside (Isoguanosine) is a natural product, which inhibits FLT3 and HDAC3/6 and has research potential …
Formula:
C10H13N5O5
Purity:
100% - 99.51%
Color and Shape:
Solid
Molecular weight:
283.24
Ref: TM-T6S0033
| 5mg | 35.00 € | ||
| 10mg | 51.00 € | ||
| 25mg | 95.00 € | ||
| 50mg | 131.00 € | ||
| 100mg | 200.00 € | ||
| 200mg | 281.00 € | ||
| 1mL*10mM (DMSO) | 35.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Merestinib dihydrochloride
CAS:1206801-37-7
Merestinib dihydrochloride (LY2801653 dihydrochloride) is a kinase inhibitor with antitumor activity that inhibits MET and …
Formula:
C30H24Cl2F2N6O3
Color and Shape:
Solid
Molecular weight:
625.45
Ref: TM-T15808
| 2mg | 67.00 € | ||
| 5mg | 128.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
BPR1J-097 hydrochloride (1327167-19-0(free base))
BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.
Formula:
C27H29ClN6O3S
Purity:
98% - 98.54%
Color and Shape:
Solid
Molecular weight:
553.07
Ref: TM-T4261
| 1mg | 50.00 € | ||
| 2mg | 66.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 155.00 € | ||
| 25mg | 270.00 € | ||
| 50mg | 457.00 € | ||
| 100mg | 655.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Pacritinib
CAS:937272-79-2
Pacritinib (SB1518) (SB1518) is an effective and specific inhibitor of JAK2 and FLT3 (IC50: 23/22 …
Formula:
C28H32N4O3
Purity:
99.25% - 99.49%
Color and Shape:
Solid
Molecular weight:
472.58
Ref: TM-T6020
| 2mg | 40.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 150.00 € | ||
| 50mg | 227.00 € | ||
| 100mg | 376.00 € | ||
| 500mg | 883.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
SGI-7079
CAS:1239875-86-5
SGI-7079: selective Axl inhibitor; hinders tumor growth dose-dependently; may target EGFR inhibitor resistance.
Formula:
C26H26FN7
Purity:
95.05% - 99.26%
Color and Shape:
Solid
Molecular weight:
455.53
Ref: TM-T6982
| 2mg | 42.00 € | ||
| 5mg | 62.00 € | ||
| 10mg | 97.00 € | ||
| 25mg | 188.00 € | ||
| 50mg | 243.00 € | ||
| 100mg | 354.00 € | ||
| 500mg | 825.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Fostamatinib Disodium
CAS:1025687-58-4
Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and …
Formula:
C23H24FN6O9P·2Na
Purity:
96.13% - 98.95%
Color and Shape:
Solid
Molecular weight:
624.42
Ref: TM-T2605
| 1mg | 47.00 € | ||
| 2mg | 55.00 € | ||
| 5mg | 88.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 221.00 € | ||
| 50mg | 374.00 € | ||
| 100mg | 560.00 € | ||
| 500mg | 1,216.00 € | ||
| 1mL*10mM (DMSO) | 116.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Fostamatinib
CAS:901119-35-5
Fostamatinib (R788)(IC50 of 41 nM), which is a prodrug of the active metabolite R406, is …
Formula:
C23H26FN6O9P
Purity:
93.08% - 99.38%
Color and Shape:
Solid
Molecular weight:
580.46
Ref: TM-T6115
| 1mg | 43.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 88.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 210.00 € | ||
| 50mg | 335.00 € | ||
| 100mg | 548.00 € | ||
| 500mg | 1,198.00 € | ||
| 1mL*10mM (DMSO) | 101.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Gilteritinib
CAS:1254053-43-4
Gilteritinib (ASP2215) is a potent inhibitor at the FMS-related tyrosine kinase 3 (FLT3) and AXL …
Formula:
C29H44N8O3
Purity:
97.75% - 99.74%
Color and Shape:
Solid
Molecular weight:
552.71
Ref: TM-T4409
| 1g | 1,359.00 € | ||
| 1mg | 40.00 € | ||
| 2mg | 55.00 € | ||
| 5mg | 89.00 € | ||
| 10mg | 120.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 276.00 € | ||
| 100mg | 434.00 € | ||
| 500mg | 1,008.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
HPK1-IN-2
CAS:2056122-11-1
HPK1-IN-2 is a strong, oral HPK1 inhibitor (IC50<0.05 μM), also blocking Lck, Flt3 kinases, …
Formula:
C19H20N6OS
Purity:
97.31%
Color and Shape:
Solid
Molecular weight:
380.47
Ref: TM-T9017
| 1mg | 78.00 € | ||
| 5mg | 143.00 € | ||
| 10mg | 230.00 € | ||
| 25mg | 385.00 € | ||
| 50mg | 548.00 € | ||
| 100mg | 730.00 € | ||
| 200mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 170.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
(E/Z)-Zotiraciclib
CAS:937270-47-8
(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 …
Formula:
C23H24N4O
Purity:
97% - 98.03%
Color and Shape:
Solid
Molecular weight:
372.46
Ref: TM-T21503
| 1mg | 46.00 € | ||
| 2mg | 59.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 210.00 € | ||
| 50mg | 349.00 € | ||
| 100mg | 507.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
SKLB4771
CAS:1370256-78-2
SKLB4771 (FLT3-IN-1) is a novel potent and selective Flt3 inhibitor.
Formula:
C25H27N7O3S2
Purity:
100% - 98.27%
Color and Shape:
Solid
Molecular weight:
537.66
Ref: TM-T2051
| 1mg | 66.00 € | ||
| 2mg | 87.00 € | ||
| 5mg | 131.00 € | ||
| 10mg | 187.00 € | ||
| 25mg | 393.00 € | ||
| 50mg | 587.00 € | ||
| 100mg | 835.00 € | ||
| 500mg | 1,700.00 € | ||
| 1mL*10mM (DMSO) | 157.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
